US2009144851A1PendingUtilityA1

Plant amino acid biosynthetic enzymes

Assignee: FALCO SAVERIO CARLPriority: Jun 12, 1997Filed: Sep 11, 2008Published: Jun 4, 2009
Est. expiryJun 12, 2017(expired)· nominal 20-yr term from priority
C12N 15/8251C12N 9/0008C12N 15/8254C12N 9/1205C12N 15/8253C12N 9/88
60
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

This invention relates to an isolated nucleic acid fragment encoding a plant cysteine γ synthase. The invention also relates to the construction of a chimeric gene encoding all or a portion of the plant cysteine γ synthase, in sense or antisense orientation, wherein expression of the chimeric gene results in production of altered levels of the plant biosynthetic enzyme in a transformed host cell.

Claims

exact text as granted — not AI-modified
1 . An isolated polynucleotide that encodes a plant cysteine γ synthase having amino acid sequence identity of at least 95% based on the Clustal method of alignment when compared to a polypeptide selected from the group consisting of SEQ ID NOs:31, 62, and 64. 
     
     
         2 . The polynucleotide of  claim 1  wherein the polynucleotide encodes a polypeptide selected from the group consisting of SEQ ID NOs: NOs:31, 62, and 64. 
     
     
         3 . The polynucleotide of  claim 1 , wherein the polynucleotide comprises a nucleotide sequence selected from the group consisting of SEQ ID NO:30, 61, and 63. 
     
     
         4 . An isolated complement of the polynucleotide of  claim 1 , wherein (a) the complement and the polynucleotide consist of the same number of nucleotides, and (b) the nucleotide sequences of the complement and the polynucleotide have 100% complementarity. 
     
     
         5 . An isolated nucleic acid molecule that (1) comprises at least 180 nucleotides (2) remains hybridized with a polynucleotide having a nucleotide sequence selected from the group consisting of SEQ ID NO:30, 61, and 63 under a wash condition of 0.1×SSC, 0.1% SDS, and 65° C., and encodes a plant cysteine γ synthase. 
     
     
         6 . A cell comprising the polynucleotide of  claim 1 . 
     
     
         7 . The cell of  claim 6 , wherein the cell is selected from the group consisting of a yeast cell, a bacterial cell and a plant cell. 
     
     
         8 . A transgenic plant comprising the polynucleotide of  claim 1 . 
     
     
         9 . A method for transforming a cell comprising introducing into a cell the polynucleotide of  claim 1 . 
     
     
         10 . A method for producing a transgenic plant comprising (a) transforming a plant cell with the polynucleotide of  claim 1 , and (b) regenerating a plant from the transformed plant cell. 
     
     
         11 . A method for producing a polynucleotide fragment comprising (a) selecting a nucleotide sequence comprised by the polynucleotide of  claim 1 , and (b) synthesizing a polynucleotide fragment containing the nucleotide sequence. 
     
     
         12 . The method of  claim 11 , wherein the fragment is produced in vivo. 
     
     
         13 . A chimeric gene comprising the polynucleotide of  claim 1  operably linked to at least one regulatory sequence. 
     
     
         14 . A method for altering the level of cysteine γ synthase expression in a host cell, the method comprising:
 (a) Transforming a host cell with the chimeric gene of  claim 13 ; and   (b) growing the transformed cell from step (a) under conditions suitable for the expression of the chimeric gene.   
     
     
         15 . A method for evaluating a compound for its ability to inhibit the activity of a plant cysteine γ synthase, the method comprising the steps of:
 (a) transforming a host cell with a chimeric gene comprising a polynucleotide of  claim 1 , operably linked to at least one regulatory sequence;   (b) growing the transformed host cell under conditions that are suitable for expression of the chimeric gene wherein expression of the chimeric gene results in production of the plant biosynthetic enzyme encoded by the operably linked nucleic acid fragment in the transformed host cell;   (c) optionally purifying the plant biosynthetic enzyme polypeptide expressed by the transformed host cell;   (d) treating the plant biosynthetic enzyme with a compound to be tested;   (e) comparing the activity of the plant biosynthetic enzyme that has been treated with a test compound to the activity of an untreated plant biosynthetic enzyme polypeptide; and   (f) selecting the compound that inhibits the activity of cysteine γ synthase.   
     
     
         16 . An isolated polynucleotide comprising:
 (a) a nucleotide sequence encoding a polypeptide having plant amino acid biosynthetic activity, wherein the polypeptide has an amino acid sequence identity of at least 90% based on the Clustal method of alignment, when compared to a polypeptide selected from the group consisting of SEQ ID NOs: 2, 4, 6, 9, 11, 13, 15, 17, 19, 22, 24, 26, 28, 34, 36, 38, and 40, or   (b) a complement of the nucleotide sequence, wherein the complement and the nucleotide sequence consist of the same number of nucleotides and are 100% complementary.   
     
     
         17 . The isolated polynucleotide of  claim 1 , wherein the amino acid sequence of the polypeptide has at least 95% sequence identity based on the Clustal method of alignment when compared to a polypeptide selected from the group consisting of SEQ ID NOs: 2, 4, 6, 9, 11, 13, 15, 17, 19, 22, 24, 26, 28, 34, 36, 38, and 40. 
     
     
         18 . The isolated polynucleotide of  claim 1 , wherein the polynucleotide encodes a polypeptide selected from the group consisting of SEQ ID NOs: 2, 4, 6, 9, 11, 13, 15, 17, 19, 22, 24, 26, 28, 34, 36, 38, and 40. 
     
     
         19 . The isolated polynucleotide of  claim 1 , wherein the polynucleotide comprises a nucleotide sequence selected from the group consisting of SEQ ID NOs:1, 3, 5, 8, 10, 12, 14, 16, 18, 21, 23, 25, 27, 33, 35, 37, and 39. 
     
     
         20 . An isolated nucleic acid molecule that (1) comprises at least 180 nucleotides and (2) remains hybridized with a polynucleotide having a nucleotide sequence selected from the group consisting of SEQ ID NOs:1, 3, 5, 8, 10, 12, 14, 16, 18, 21, 23, 25, 27, 33, 35, 37, and 39 under a wash condition of 0.1×SSC, 0.1% SDS, and 65° C. 
     
     
         21 . A cell comprising the polynucleotide of  claim 16 . 
     
     
         22 . The cell of  claim 21 , wherein the cell is selected from the group consisting of a yeast cell, a bacterial cell, and a plant cell. 
     
     
         23 . A transgenic plant comprising the polynucleotide of  claim 16 . 
     
     
         24 . A method for transforming a cell comprising introducing into a cell the polynucleotide of  claim 16 . 
     
     
         25 . A method for producing a transgenic plant comprising:
 (a) transforming a plant cell with the polynucleotide of  claim 16 , and   (b) regenerating a plant from the transformed plant cell.   
     
     
         26 . A method for producing a polynucleotide fragment comprising:
 (a) selecting a nucleotide sequence comprised by the polynucleotide of  claim 16 , and   (b) synthesizing a polynucleotide fragment containing the nucleotide sequence.   
     
     
         27 . The method of  claim 26 , wherein the fragment is produced in vivo. 
     
     
         28 . A chimeric gene comprising the polynucleotide of  claim 16  operably linked to at least one regulatory sequence. 
     
     
         29 . A method for altering the level of expression of a plant amino acid biosynthetic enzyme in a host cell, the method comprising:
 (a) transforming a host cell with the chimeric gene of  claim 28 ; and   (b) growing the transformed cell from step (a) under conditions suitable for the expression of the chimeric gene.

Join the waitlist — get patent alerts

Track US2009144851A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.